Evidence map›Paper›PMID 29525779›Full record

ArticleJournal of the American Heart Association2018

Non-ST-Segment-Elevation Myocardial Infarction Among Patients With Chronic Kidney Disease: A Propensity Score-Matched Comparison of Percutaneous Coronary Intervention Versus Conservative Management.

Subir Bhatia, Shilpkumar Arora, Sravya M Bhatia, Mohammed Al-Hijji, Yogesh N V Reddy, Parshva Patel, Charanjit S Rihal, Bernard J Gersh, Abhishek Deshmukh

Open access · goldAbstract readComparative Study
In one paragraph

Article in Journal of the American Heart Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Coronary Artery Disease in CKD-G5D Patients: An Update.Reviews in cardiovascular medicine · 2023
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Subir BhatiaDepartment of Internal Medicine, Mayo Clinic, Rochester, MN.
Shilpkumar AroraMt. Sinai St. Luke's, New York, NY.
Sravya M BhatiaDuke University School of Medicine, Durham, NC.
Mohammed Al-HijjiDepartment of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
Yogesh N V ReddyDepartment of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
Parshva PatelDepartment of Internal Medicine, Drexel University College of Medicine, Philadelphia, PA.
Charanjit S RihalDepartment of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
Bernard J GershDepartment of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
Abhishek DeshmukhDepartment of Cardiovascular Diseases, Mayo Clinic, Rochester, MN deshmukh.abhishek@mayo.edu.
Mayo Clinic in Arizona · USDrexel University · USMayo Clinic in Florida · USSt. Luke's Hospital · USWinnMed · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic kidney disease (CKD) remains an independent predictor of cardiovascular morbidity and mortality. CKD complicates referral for percutaneous coronary intervention (PCI) in non-ST-segment-elevation myocardial infarction (NSTEMI) patients because of the risk for acute kidney injury and the need for dialysis, with American College of Cardiology/American Heart Association guidelines underscoring the limited data on these patients. METHODS AND

resultsUsing the National Inpatient Sample to analyze hospitalizations in the United States from 2004 to 2014, we sought to assess PCI utilization and in-hospital outcomes in NSTEMI admissions with CKD. NSTEMI admissions were identified by

conclusionsPCI use decreased among hospitalized NSTEMI patients as CKD severity increased, and all-cause, in-hospital mortality was greater for NSTEMI patients admitted with more severe CKD regardless of treatment strategy.

Indexed as

Conservative TreatmentPercutaneous Coronary InterventionAdolescentAdultAgedAged, 80 and overDatabases, FactualFemaleHospital MortalityHumansInpatientsMaleMiddle AgedNon-ST Elevated Myocardial InfarctionPropensity ScoreRenal Dialysisacute coronary syndromechronic kidney disease

Identifiers

PMID29525779
PMCPMC5907556
OpenAlexW2792741773

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.